Timeline
Segro and Pure Data Centres Group form new JV in Paris
Segro doubles new rent secured in first half as development pipeline hits record
Segro confirms UK logistics joint venture targeting £3bn gross asset value
Segro rejects Prologis takeover approach as inadequate
Deutsche Bank gives its take on Prologis approach
SEGRO Logistics JV Prices €650 Million Seven-Year Bond at 4%
SEGRO reiterates £450-550m development capex guidance after strong Q1
More in Pharma
Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer
Positive overall survival data from a China trial of risvutatug rezetecan marks the first Phase III success for any B7-H3-targeted antibody-drug conjugate, strengthening GSK's broader development programme.